1. Medtech Insight
  2. >>Geography
  3. >>Asia

Pakistan Acts To Harmonize Disclosure Of Medtech Payments To Doctors

 
• By Vibha Sharma

Pakistan’s drug regulator has come up with a strategy to ensure uniformity in how medical device and pharma companies disclose the money they spend on doctors and medical institutes under new ethical marketing rules.

Team of doctors and businesswoman having a meeting in medical office
Pakistan Wants To Improve Transparency On Interactions Between Drug & Device Companies And Health Care Professionals • Source: Shutterstock

The Drug Regulatory Authority of Pakistan is taking steps to ensure that drug and medical device companies follow a harmonized approach when it comes to disclosing the expenses they incur every year as part of their product marketing activities involving health care professionals and medical institutes.

Companies are required to make such disclosures to the DRAP and relevant tax authorities under the “Ethical Marketing to Healthcare Professionals (EMHP) Rules,” which came into force in November 2021....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Asia

More from Geography

Pathogen Sharing System Part Of Global Pandemic Agreement

 
• By Neena Brizmohun

Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.

FDA Halts Acceptance Of Chinese Lab Data Due To Accuracy Issues

 
• By Elizabeth Orr

The FDA has stopped accepting data from two Chinese labs due to accuracy issues. Mid-Link and SDWH have been flagged for potentially falsified results and other misconduct. This decision, which follows months of discussions and warnings, emphasizes the FDA's commitment to ensuring data integrity in medical device submissions.

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.